Angiotensin II-induced protein kinase D activates the ATF/CREB family of transcription factors and promotes StAR mRNA expression.

Endocrinology

Charlie Norwood Veterans Administration Medical Center (L.O.O., V.C., W.B.B.), Augusta, Georgia 30904; and Departments of Physiology (L.O.O., V.C., W.B.B.), Biostatistics and Epidemiology (M.H.J.), and Cell Biology and Anatomy and Medicine and Orthopaedic Surgery (W.B.B.), Medical College of Georgia at Georgia Regents University, Augusta, Georgia 30912.

Published: July 2014

Aldosterone synthesis is initiated upon the transport of cholesterol from the outer to the inner mitochondrial membrane, where the cholesterol is hydrolyzed to pregnenolone. This process is the rate-limiting step in acute aldosterone production and is mediated by the steroidogenic acute regulatory (StAR) protein. We have previously shown that angiotensin II (AngII) activation of the serine/threonine protein kinase D (PKD) promotes acute aldosterone production in bovine adrenal glomerulosa cells, but the mechanism remains unclear. Thus, the purpose of this study was to determine the downstream signaling effectors of AngII-stimulated PKD activity. Our results demonstrate that overexpression of the constitutively active serine-to-glutamate PKD mutant enhances, whereas the dominant-negative serine-to-alanine PKD mutant inhibits, AngII-induced StAR mRNA expression relative to the vector control. PKD has been shown to phosphorylate members of the activating transcription factor (ATF)/cAMP response element binding protein (CREB) family of leucine zipper transcription factors, which have been shown previously to bind the StAR proximal promoter and induce StAR mRNA expression. In primary glomerulosa cells, AngII induces ATF-2 and CREB phosphorylation in a time-dependent manner. Furthermore, overexpression of the constitutively active PKD mutant enhances the AngII-elicited phosphorylation of ATF-2 and CREB, and the dominant-negative mutant inhibits this response. Furthermore, the constitutively active PKD mutant increases the binding of phosphorylated CREB to the StAR promoter. Thus, these data provide insight into the previously reported role of PKD in AngII-induced acute aldosterone production, providing a mechanism by which PKD may be mediating steroidogenesis in primary bovine adrenal glomerulosa cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060184PMC
http://dx.doi.org/10.1210/en.2013-1485DOI Listing

Publication Analysis

Top Keywords

pkd mutant
16
star mrna
12
mrna expression
12
acute aldosterone
12
aldosterone production
12
glomerulosa cells
12
constitutively active
12
pkd
9
protein kinase
8
transcription factors
8

Similar Publications

Autosomal dominant polycystic kidney disease (ADPKD) is a predominant genetic disease, which is caused by mutations in PKD genes and is associated with DNA damage in cystic cells. The intrinsic stimulator of interferon genes (STING) pathway is crucial for recognizing damaged DNA in the cytosol, triggering the expression of inflammatory cytokines to activate defense mechanisms. However, the precise roles and mechanisms of STING in ADPKD remain elusive.

View Article and Find Full Text PDF

Protein kinase D2 modulates hepatic insulin sensitivity in male mice.

Mol Metab

December 2024

Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain. Electronic address:

Article Synopsis
  • The study investigates the role of protein kinase D2 (PKD2) in regulating insulin signaling and metabolic homeostasis in the liver, as its functions are not yet fully understood.
  • Using various experimental methods, including PKD2 overexpression and specific gene depletion in mouse models, researchers assessed how PKD2 affects insulin responses and glucose metabolism.
  • Findings reveal that PKD2 inhibits insulin signaling by modifying the phosphorylation of insulin receptor substrate 1 (IRS1), and suggest that PKD2 could be targeted therapeutically to combat hepatic insulin resistance.
View Article and Find Full Text PDF

High-grade glial cancers typically arise in the cerebral hemisphere and rarely in the cerebellum. Our objective was to highlight the diagnostic features of isocitrate dehydrogenase (IDH)-mutant high-grade gliomas in the cerebellum. We present a case of an elderly patient admitted with giddiness who was diagnosed with IDH-mutant high-grade glioma in the cerebellum, presenting as multiple lesions.

View Article and Find Full Text PDF

Identification and Properties of TRPV4 Mutant Channels Present in Polycystic Kidney Disease Patients.

Function (Oxf)

September 2024

Departamento de Neurociencia Cognitiva, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.

Article Synopsis
  • * TRPV4 and TRPP2 channels interact in kidney cell physiology, and mutations in TRPV4 could affect kidney function, potentially worsening PKD severity.
  • * PKD patients with TRPV4 mutations may face increased risks of requiring dialysis or kidney transplants compared to those without these mutations.
View Article and Find Full Text PDF

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency.

Ann Neurol

October 2024

Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, Fujian, China.

Objective: Most paroxysmal kinesigenic dyskinesia (PKD) cases are hereditary, yet approximately 60% of patients remain genetically undiagnosed. We undertook the present study to uncover the genetic basis for undiagnosed PKD patients.

Methods: Whole-exome sequencing was performed for 106 PRRT2-negative PKD probands.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!